Board of Directors

Wenche Rolfsen, Chairman
PhD in Pharmacology and adjunct professorship at Uppsala University.
Previously 16 years experience in leading positions within preclinical research and development at Pharmacia. Responsible for the early clinical organization at Quintiles Europe and president of Quintiles Scandinavia for a total of 11 years.
Other assignments: Chairman of the Board of Aprea AB and Denator AB. Board member of Swedish Orphan Biovitrum AB, Industrifonden AB, TFS AB and Aker Biomarine AS.

Viktor Drvota
Associate Professor, M.D., PhD
Viktor Drvota is responsible for Business Development/Life science at SEB Venture Capital. Before joining SEB in 2002, he worked as Senior Consultant and Associate Professor in Cardiology at the Karolinska Institutet, Stockholm. He has experience from preclinical as well as clinical research in drug development and medical devices both in academia and in pharmaceutical industry.
Other assignments: Member of the Boards of Sanos A/S, Nuevolution A/S, Scibase AB and Airsonett AB.

Hans Engblom
Hans Engblom is Senior Investment Manager at SEB Venture Capital since 1997. He has had board positions in many public and private companies in various industries.
Other assignments: Member of the Board of Cobolt AB.

Lennart Hansson
PhD in genetics
Investment Director Life Science at Industrifonden. Previously in executive positions at KabiGen, Symbicom, and AstraZeneca. Also former CEO at Arexis and investment manager at Karolinska Development.